Outcome of Anticoagulant Therapy Following Bariatric Surgery
George Mamdouh Aziz Abd ELMalaak;
Abstract
Bariatric surgery remains the most effective means of treating severe obesity. The number of severely obese patients is increasing and, consequently, more people are seeking bariatric surgery.
VTE remains the most worrying complication.
A full Risk profile assessment should be done on history. In patients with a history of VTE not previously investigated, a Thrombotic profile must be.
It is advised that a baseline anti-Xa level should be measured, if indicated
• LMWH and NOA can be start post-operatively.
• Obesity is main cause of V.T.E
• Enoxaparin 40 mg daily and NOA 10mg daily are mostly used
• Most patients need to continue with anticoagulation for 7–21 days depending of individual risk assessment.
• In patients with a very high-risk profile for VTEs, LMWH and NOA doses should be continue for a minimum of
VTE remains the most worrying complication.
A full Risk profile assessment should be done on history. In patients with a history of VTE not previously investigated, a Thrombotic profile must be.
It is advised that a baseline anti-Xa level should be measured, if indicated
• LMWH and NOA can be start post-operatively.
• Obesity is main cause of V.T.E
• Enoxaparin 40 mg daily and NOA 10mg daily are mostly used
• Most patients need to continue with anticoagulation for 7–21 days depending of individual risk assessment.
• In patients with a very high-risk profile for VTEs, LMWH and NOA doses should be continue for a minimum of
Other data
| Title | Outcome of Anticoagulant Therapy Following Bariatric Surgery | Other Titles | نتائــج العــلاج المضــاد للتخثــر بعد إجــراء جراحــات السمنــة | Authors | George Mamdouh Aziz Abd ELMalaak | Issue Date | 2019 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.